JACOBS LEVY EQUITY MANAGEMENT, INC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,390,966
-47.5%
405,618
+56.0%
0.02%
-45.9%
Q2 2023$6,457,183
+65.2%
259,9510.0%0.04%
+54.2%
Q1 2023$3,909,663
-10.1%
259,951
-29.3%
0.02%
-17.2%
Q4 2022$4,347,206
+552.7%
367,473
+226.7%
0.03%
+480.0%
Q3 2022$666,000
+42.9%
112,495
+370.7%
0.01%0.0%
Q2 2020$466,000
+86.4%
23,900
-5.9%
0.01%
+66.7%
Q1 2020$250,000
-86.7%
25,401
-85.0%
0.00%
-83.3%
Q4 2019$1,878,000
+177.8%
169,200
+40.5%
0.02%
+125.0%
Q3 2019$676,000
-27.6%
120,400
+11.5%
0.01%
-38.5%
Q2 2019$934,000
+166.1%
108,000
+304.3%
0.01%
+116.7%
Q2 2018$351,00026,7100.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders